Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study.
Mamoru ShibataTomomi NakamuraAkichika OzekiKaname UedaRussell M NicholsPublished in: Journal of pain research (2020)
ClinicalTrials.gov, NCT02959177 (registered November 7, 2016).